204 related articles for article (PubMed ID: 29150024)
1. Decreased UCHL1 expression as a cytologic biomarker for aggressive behavior in pancreatic neuroendocrine tumors.
Moore MD; Finnerty B; Gray KD; Hoda R; Liu YF; Soong L; Beninato T; Rao R; Zarnegar R; Fahey TJ
Surgery; 2018 Jan; 163(1):226-231. PubMed ID: 29150024
[TBL] [Abstract][Full Text] [Related]
2. UCHL1 loss alters the cell-cycle in metastatic pancreatic neuroendocrine tumors.
Finnerty BM; Moore MD; Verma A; Aronova A; Huang S; Edwards DP; Chen Z; Seandel M; Scognamiglio T; Du YN; Elemento O; Zarnegar R; Min IM; Fahey TJ
Endocr Relat Cancer; 2019 Apr; 26(4):411-423. PubMed ID: 30689542
[TBL] [Abstract][Full Text] [Related]
3. Can pancreatic neuroendocrine tumour biopsy accurately determine pathological characteristics?
Rebours V; Cordova J; Couvelard A; Fabre M; Palazzo L; Vullierme MP; Hentic O; Sauvanet A; Aubert A; Bedossa P; Ruszniewski P
Dig Liver Dis; 2015 Nov; 47(11):973-7. PubMed ID: 26169284
[TBL] [Abstract][Full Text] [Related]
4. Assessment of ARX expression, a novel biomarker for metastatic risk in pancreatic neuroendocrine tumors, in endoscopic ultrasound fine-needle aspiration.
Hackeng WM; Morsink FHM; Moons LMG; Heaphy CM; Offerhaus GJA; Dreijerink KMA; Brosens LAA
Diagn Cytopathol; 2020 Apr; 48(4):308-315. PubMed ID: 31846235
[TBL] [Abstract][Full Text] [Related]
5. [Accurate grading of pancreatic neuroendocrine tumors with Ki-67 index in fine-needle aspiration specimens: a comparative cytologic and histologic study].
He SR; Cui D; Gong H; Zhu YP; Chen L; Hu ST; Liu DG
Zhonghua Bing Li Xue Za Zhi; 2017 Jun; 46(6):393-399. PubMed ID: 28591986
[No Abstract] [Full Text] [Related]
6. The role of cytomorphology and proliferative activity in predicting biologic behavior of pancreatic neuroendocrine tumors: a study by endoscopic ultrasound-guided fine-needle aspiration cytology.
Chatzipantelis P; Konstantinou P; Kaklamanos M; Apostolou G; Salla C
Cancer; 2009 Jun; 117(3):211-6. PubMed ID: 19350669
[TBL] [Abstract][Full Text] [Related]
7. Silencing of UCHL1 by CpG promoter hyper-methylation is associated with metastatic gastroenteropancreatic well-differentiated neuroendocrine (carcinoid) tumors.
Kleiman DA; Beninato T; Sultan S; Crowley MJ; Finnerty B; Kumar R; Panarelli NC; Liu YF; Lieberman MD; Seandel M; Evans T; Elemento O; Zarnegar R; Fahey TJ
Ann Surg Oncol; 2014 Dec; 21 Suppl 4(0 4):S672-9. PubMed ID: 24854489
[TBL] [Abstract][Full Text] [Related]
8. Fine-needle aspiration biopsy of pancreatic neuroendocrine tumors: Correlation between Ki-67 index in cytological samples and clinical behavior.
Díaz Del Arco C; Esteban López-Jamar JM; Ortega Medina L; Díaz Pérez JÁ; Fernández Aceñero MJ
Diagn Cytopathol; 2017 Jan; 45(1):29-35. PubMed ID: 27863178
[TBL] [Abstract][Full Text] [Related]
9. Grading by the Ki-67 Labeling Index of Endoscopic Ultrasound-Guided Fine Needle Aspiration Biopsy Specimens of Pancreatic Neuroendocrine Tumors Can Be Underestimated.
Hwang HS; Kim Y; An S; Kim SJ; Kim JY; Kim SY; Hwang DW; Park DH; Lee SS; Kim SC; Seo DW; Hong SM
Pancreas; 2018; 47(10):1296-1303. PubMed ID: 30211805
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic error assessment and associated harm of endoscopic ultrasound-guided fine-needle aspiration of neuroendocrine neoplasms of the pancreas.
Hooper K; Mukhtar F; Li S; Eltoum IA
Cancer Cytopathol; 2013 Nov; 121(11):653-60. PubMed ID: 23839928
[TBL] [Abstract][Full Text] [Related]
11. Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study.
Larghi A; Capurso G; Carnuccio A; Ricci R; Alfieri S; Galasso D; Lugli F; Bianchi A; Panzuto F; De Marinis L; Falconi M; Delle Fave G; Doglietto GB; Costamagna G; Rindi G
Gastrointest Endosc; 2012 Sep; 76(3):570-7. PubMed ID: 22898415
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic neuroendocrine tumors: accurate grading with Ki-67 index on fine-needle aspiration specimens using the WHO 2010/ENETS criteria.
Farrell JM; Pang JC; Kim GE; Tabatabai ZL
Cancer Cytopathol; 2014 Oct; 122(10):770-8. PubMed ID: 25044931
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic neuroendocrine tumour grading on endoscopic ultrasound-guided fine needle aspiration: high reproducibility and inter-observer agreement of the Ki-67 labelling index.
Weynand B; Borbath I; Bernard V; Sempoux C; Gigot JF; Hubert C; Lannoy V; Deprez PH; Jouret-Mourin A
Cytopathology; 2014 Dec; 25(6):389-95. PubMed ID: 24750272
[TBL] [Abstract][Full Text] [Related]
14. PAX8 is expressed in pancreatic well-differentiated neuroendocrine tumors and in extrapancreatic poorly differentiated neuroendocrine carcinomas in fine-needle aspiration biopsy specimens.
Haynes CM; Sangoi AR; Pai RK
Cancer Cytopathol; 2011 Jun; 119(3):193-201. PubMed ID: 21328566
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic neuroendocrine neoplasm: correlation between computed tomography enhancement patterns and prognostic factors of surgical and endoscopic ultrasound-guided fine-needle aspiration biopsy specimens.
Tatsumoto S; Kodama Y; Sakurai Y; Shinohara T; Katanuma A; Maguchi H
Abdom Imaging; 2013 Apr; 38(2):358-66. PubMed ID: 22945422
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced harmonic endoscopic ultrasound-guided fine-needle aspiration in the diagnosis of solid pancreatic lesions: a retrospective study.
Hou X; Jin Z; Xu C; Zhang M; Zhu J; Jiang F; Li Z
PLoS One; 2015; 10(3):e0121236. PubMed ID: 25793739
[TBL] [Abstract][Full Text] [Related]
17. Cystic pancreatic endocrine tumors: an endoscopic ultrasound-guided fine-needle aspiration biopsy study with histologic correlation.
Charfi S; Marcy M; Bories E; Pesanti C; Caillol F; Giovannini M; Viret F; Robert Delpero J; Xerri L; Monges G
Cancer; 2009 Jun; 117(3):203-10. PubMed ID: 19365841
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading.
Sugimoto M; Takagi T; Hikichi T; Suzuki R; Watanabe K; Nakamura J; Kikuchi H; Konno N; Waragai Y; Asama H; Takasumi M; Watanabe H; Obara K; Ohira H
World J Gastroenterol; 2015 Jul; 21(26):8118-24. PubMed ID: 26185384
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin receptor expression related to TP53 and RB1 alterations in pancreatic and extrapancreatic neuroendocrine neoplasms with a Ki67-index above 20.
Konukiewitz B; Schlitter AM; Jesinghaus M; Pfister D; Steiger K; Segler A; Agaimy A; Sipos B; Zamboni G; Weichert W; Esposito I; Pfarr N; Klöppel G
Mod Pathol; 2017 Apr; 30(4):587-598. PubMed ID: 28059098
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of Pancreatic Neuroendocrine Tumour Grading by Endoscopic Ultrasound-Guided Fine Needle Aspiration: Analysis of a Large Cohort and Perspectives for Improvement.
Boutsen L; Jouret-Mourin A; Borbath I; van Maanen A; Weynand B
Neuroendocrinology; 2018; 106(2):158-166. PubMed ID: 28494461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
